PharmaCyte Biotech (PMCB) Non Operating Investment Income (2025 - 2026)
PharmaCyte Biotech (PMCB) posted quarterly Non Operating Investment Income of -$118241.0 for Q2 2026, down 1772.09% year-over-year from $7071.5 in Q2 2025, and up 8.3% quarter-over-quarter from -$128939.0 in Q1 2026.
PharmaCyte Biotech (PMCB) Non Operating Investment Income (2025 - 2026) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Non Operating Investment Income for 2 consecutive years, with -$118241.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Non Operating Investment Income fell 1772.09% year-over-year to -$118241.0; the TTM figure through Apr 2026 stood at -$412306.0 (down 721.73% YoY), while the FY2026 annual figure was -$412306.0, down 721.73% from the prior year.
- Non Operating Investment Income rose to -$118241.0 in Q2 2026 per PMCB's latest filing, from -$128939.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $72632.0 in Q1 2025 and bottomed at -$128939.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | -118,241.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -118,241.00 |
| Apr 30, 2026 | -118,241.00 |
| Jan 31, 2026 | -128,939.00 |
| Jan 31, 2026 | -128,939.00 |
| Oct 31, 2025 | -60,663.00 |
| Oct 31, 2025 | -60,663.00 |
| Jul 31, 2025 | -104,463.00 |
| Jul 31, 2025 | -104,463.00 |
| Apr 30, 2025 | -6,316.00 |
| Apr 30, 2025 | -6,316.00 |
| Jan 31, 2025 | 72,632.00 |
| Jan 31, 2025 | 72,632.00 |